Related Articles
Downregulation of BCSG1 may correlate with better outcome of neoadjuvant chemotherapy for triple-negative breast cancer
Clinical significance of androgen receptor expression in triple negative breast cancer‑an immunohistochemistry study
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis